Conduit Pharmaceuticals Inc (NASDAQ:CDT) shares traded -14.94% lower at $0.91 on Wall Street last session.
CDT stock price is now -23.44% away from the 50-day moving average and -92.80% away from the 200-day moving average. The market capitalization of the company currently stands at $8.69M.
In other news, Nirland Ltd, 10% Owner sold 1,500,000 shares of the company’s stock on Oct 03 ’24. The stock was sold for $156,450 at an average price of $0.10. Upon completion of the transaction, the 10% Owner now directly owns 8,400,000 shares in the company, valued at $7.64 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Oct 04 ’24, 10% Owner Nirland Ltd sold 1,368,991 shares of the business’s stock. A total of $140,458 was realized by selling the stock at an average price of $0.10. This leaves the insider owning 7,031,009 shares of the company worth $6.4 million. A total of 13.01% of the company’s stock is owned by insiders.
During the past 12 months, Conduit Pharmaceuticals Inc has had a low of $0.51 and a high of $350.00. The fifty day moving average price for CDT is $1.18876 and a two-hundred day moving average price translates $12.63959 for the stock.
The latest earnings results from Conduit Pharmaceuticals Inc (NASDAQ: CDT) was released for 2024-12-31. The company reported revenue of $3.51 million for the quarter, compared to $2.43 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 44.63 percent.
